An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia-Reference-Cited by-同舟云学术

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia

Published:2005-12-08 Issue:2 Volume:57 Page:317-325
ISSN:1460-2091
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Glasmacher Axel,Cornely Oliver,Ullmann Andrew J.,Wedding Ulrich,Bodenstein Heinrich,Wandt Hannes,Boewer Christian,Pasold Rita,Wolf Hans-Heinrich,Hänel Mathias,Dölken Gottfried,Junghanss Christian,Andreesen Reinhard,Bertz Hartmut

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/57/2/317/2407659/dki440.pdf

Reference38 articles.

1. Prentice HG, Kibbler CC, Prentice AG. Towards a targeted, risk-based, antifungal strategy in neutropenic patients. Br J Haematol2000; 110: 273–84.

2. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis2001; 32: 358–66.

3. Viscoli C, Girmenia C, Marinus A et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis1999; 28: 1071–9.

4. Marr KA, Seidel K, White TC et al. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis2000; 181: 309–16.

5. Maertens J, van Eldere J, Verhaegen J et al. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis2002; 186: 1297–306.

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II trial of posaconazole prophylaxis during anti‐thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome;British Journal of Haematology;2024-05-03

2. Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation;Journal of Antimicrobial Chemotherapy;2023-03-20

3. Impact of Concomitant Use of Azoles on Bortezomib-related Adverse Drug Reactions Using JADER;Anticancer Research;2023-02-28

4. Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies;BMC Cancer;2021-04-14

5. Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation;JAMA Network Open;2020-10-08